Streetbeat News

Stock Prices

STLA

Stellantis (NYSE:STLA) announced the start of limited production of its medium electric van, Vivaro Electric, at its Luton manufacturing facility in the first half of 2025. This move marks Stellantis' further commitment to electric vehicle (EV) production in the U.K., with Luton becoming its second plant in the country dedicated to EVs. The company's shares rose 3.00% to $26.38 following the announcement.

Portfolio Pulse from Lekha Gupta

February 22, 2024 | 4:20 pm

GBNH

Greenbrook TMS Inc (NASDAQ:GBNH) shares plummeted 44.5% to $0.21 after announcing a direct offering of 6 million shares at $0.20 each, aiming to raise $1.2 million for working capital and general purposes. A.G.P./Alliance Global Partners is the placement agent for the offering, expected to close on February 26.

Portfolio Pulse from Henry Khederian

February 22, 2024 | 4:20 pm

MOS

During a conference call, the CEO of Mosaic (MOS) indicated that there are early signs of an increase in potash prices. This could signal a positive outlook for the company's future revenue and profitability, given its role in the potash industry.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 4:20 pm

WRAC

Williams Rowland Acquisition Corp. (WRAC) announced it will liquidate and dissolve, redeeming all outstanding public shares effective March 8, 2024, due to its inability to complete an initial business combination by March 29, 2024. The company will cease operations except for winding up, redeem public shares with funds from its trust account, and dissolve following stockholder and board approval. WRAC's securities will stop trading on the NYSE American on February 29, 2024, and it plans to delist and terminate the registration of its securities.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 4:18 pm

BTCUSD

Cryptocurrency expert Kevin Svenson predicts a significant downturn for Bitcoin following the upcoming halving event, suggesting a potential dip to as low as $44,000 after a short-squeeze target of $60,000. This prediction contrasts with other analysts' more bullish expectations and highlights the potential for volatility and corrections in the cryptocurrency market.

Portfolio Pulse from Murtuza Merchant

February 22, 2024 | 4:17 pm

DPRO

Draganfly Inc. (NASDAQ:DPRO) shares plummeted by 48.4% to $0.18 after announcing a $3.6 million underwritten public offering at $0.27 per unit. The offering includes 13.4 million units, each comprising one common share (or pre-funded warrant) and one warrant to purchase one common share at $0.36, expiring in five years. Maxim Group LLC is managing the offering, with proceeds aimed at general corporate purposes, including product development and potential acquisitions. The offering is expected to close by February 26, subject to regulatory approvals.

Portfolio Pulse from Henry Khederian

February 22, 2024 | 4:16 pm

LNTH

Lantheus Holdings' shares surged following the announcement of their Q4 financial results, which exceeded expectations. Additionally, the company provided optimistic revenue guidance for Q1 and the full year 2024, both surpassing analysts' forecasts.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 4:14 pm

LKQ

LKQ Corp reported a 16.6% year-over-year sales growth in Q4 fiscal 2023, reaching $3.50 billion but slightly missing the consensus of $3.51 billion. Parts and services organic revenue grew by 2.8%. The company saw a contraction in gross margin and operating income, but adjusted EPS improved to $0.84, beating the consensus. LKQ declared a quarterly dividend of $0.30 per share and repurchased shares. The 2024 outlook includes an adjusted EPS of $3.90-$4.20 and organic revenue growth of 3.5% - 5.5%. LKQ shares rose 3.3% to $51.99.

Portfolio Pulse from Akanksha Bakshi

February 22, 2024 | 4:11 pm

MRNA

Moderna Inc (NASDAQ:MRNA) reported Q4 2023 revenues of $2.81 billion from its COVID-19 vaccine, Spikevax, surpassing the $2.49 billion consensus. Despite a 43% Y/Y decline in net product sales to $2.8 billion due to lower sales volume, the company achieved a quarterly profit with an EPS of $0.55, beating the $(0.97) consensus. Moderna's market share in the U.S. retail segment for the COVID vaccine increased to 48% in fall 2023. The company also anticipates initial regulatory approvals for its RSV vaccine in the first half of 2024 and expects $4 billion in revenue from its respiratory franchise in 2024.

Portfolio Pulse from Vandana Singh

February 22, 2024 | 4:11 pm

NOVA

Sunnova Energy's shares dropped following the announcement of their Q4 financial results, which fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 4:09 pm